Acorda Therapeutics, Inc. (NASDAQ: ACOR) will present at the Deutsche Bank 2009 Biotech Boston Confab. The company is scheduled to present on December 15, 2009 at 2:05pm (ET). The conference is being held in Boston, MA, at the Four Seasons Hotel Boston. The company's President and CEO, Ron Cohen, M.D., will host the presentation. A live webcast will be available through the Investor Relations section of the company's website. A replay will remain available through March 15, 2010.
MicroCap Insider is a web-based financial portal that publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors. Sign Up for our Free Stock Newsletter
About Acorda Therapeutics
Acorda Therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. The Company's marketed products include Zanaflex Capsules® (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.
Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer
